Pharmacokinetics and pharmacodynamics of curcumin
- PMID: 17569224
- DOI: 10.1007/978-0-387-46401-5_20
Pharmacokinetics and pharmacodynamics of curcumin
Abstract
Curcuma spp. contain turmerin, essential oils, and curcuminoids, including curcumin. Curcumin [1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione] is regarded as the most biologically active constituent of the spice turmeric and it comprises 2-8% of most turmeric preparations. Preclinical data from animal models and phase I clinical studies performed with human volunteers and patients with cancer have demonstrated low systemic bioavailability following oral dosing. Efficient first-pass metabolism and some degree of intestinal metabolism, particularly glucuronidation and sulfation of curcumin, might explain its poor systemic availability when administered via the oral route. A daily oral dose of 3.6 g of curcumin is compatible with detectable levels of the parent compound in colorectal tissue from patients with cancer. The levels demonstrated might be sufficient to exert pharmacological activity. There appears to be negligible distribution of the parent drug to hepatic tissue or other tissues beyond the gastrointestinal tract. Curcumin possesses wide-ranging anti-inflammatory and anticancer properties. Many of these biological activities can be attributed to its potent antioxidant capacity at neutral and acidic pH, its inhibition of cell signaling pathways at multiple levels, its diverse effects on cellular enzymes, and its effects on cell adhesion and angiogenesis. In particular, curcumin's ability to alter gene transcription and induce apoptosis in preclinical models advocates its potential utility in cancer chemoprevention and chemotherapy. With regard to considerable public and scientific interest in the use of phytochemicals derived from dietary components to combat or prevent human diseases, curcumin is currently a leading agent.
Similar articles
-
Curcumin: the story so far.Eur J Cancer. 2005 Sep;41(13):1955-68. doi: 10.1016/j.ejca.2005.05.009. Eur J Cancer. 2005. PMID: 16081279 Review.
-
Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.Arch Pharm (Weinheim). 2010 Sep;343(9):489-99. doi: 10.1002/ardp.200900319. Arch Pharm (Weinheim). 2010. PMID: 20726007 Review.
-
Curcumin and neurodegenerative diseases: a perspective.Expert Opin Investig Drugs. 2012 Aug;21(8):1123-40. doi: 10.1517/13543784.2012.693479. Epub 2012 Jun 6. Expert Opin Investig Drugs. 2012. PMID: 22668065 Review.
-
Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects.Molecules. 2019 Aug 13;24(16):2930. doi: 10.3390/molecules24162930. Molecules. 2019. PMID: 31412624 Free PMC article. Review.
-
Pharmacokinetics, Pharmacodynamics, and PKPD Modeling of Curcumin in Regulating Antioxidant and Epigenetic Gene Expression in Healthy Human Volunteers.Mol Pharm. 2019 May 6;16(5):1881-1889. doi: 10.1021/acs.molpharmaceut.8b01246. Epub 2019 Mar 28. Mol Pharm. 2019. PMID: 30860383 Free PMC article.
Cited by
-
Development of a rapid, sensitive, and selective LC-MS/MS method for quantifying curcumin levels in healthy human urine: Effect of pepper on curcumin bioavailability.Food Sci Nutr. 2023 Sep 18;11(12):7732-7741. doi: 10.1002/fsn3.3691. eCollection 2023 Dec. Food Sci Nutr. 2023. PMID: 38107126 Free PMC article.
-
Turmeric and Curcumin-Health-Promoting Properties in Humans versus Dogs.Int J Mol Sci. 2023 Sep 26;24(19):14561. doi: 10.3390/ijms241914561. Int J Mol Sci. 2023. PMID: 37834009 Free PMC article. Review.
-
Curcumin's effect on serum zinc, copper and magnesium levels in obese individuals.Avicenna J Phytomed. 2023 May-Jun;13(3):223-230. doi: 10.22038/AJP.2022.21517. Avicenna J Phytomed. 2023. PMID: 37654996 Free PMC article.
-
Mechanistic insights into the anti-depressant effect of curcumin based on network pharmacology and experimental validation.Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):583-598. doi: 10.1007/s00210-023-02628-w. Epub 2023 Jul 25. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37490124
-
Lysosomes, curcumin, and anti-tumor effects: how are they linked?Front Pharmacol. 2023 Jul 7;14:1220983. doi: 10.3389/fphar.2023.1220983. eCollection 2023. Front Pharmacol. 2023. PMID: 37484013 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
